CompaniesPardes Biosciences

Pardes Biosciences

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

372

By Phase

PHASE2: 1PHASE1: 1

By Status

TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details

Recent Trials

NCT05543707Lead Sponsor
PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19
PHASE2Terminated
242 participants
Started: Sep 21, 2022 · Completed: Apr 14, 2023
NCT05011812Lead Sponsor
Study of PBI-0451 in Healthy Subjects.
PHASE1Completed
130 participants
Started: Aug 14, 2021 · Completed: Mar 26, 2022
Funding History (1)
D
Feb 3, 2021
Filing
Related Companies
Medipacific
acquired